{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:20:11Z","timestamp":1781094011599,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.drugalcdep.2011.06.020","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T02:36:52Z","timestamp":1311820612000},"page":"201-206","source":"Crossref","is-referenced-by-count":13,"title":["Can intranasal drug use reduce HCV infection among injecting drug users?"],"prefix":"10.1016","volume":"119","author":[{"given":"Don C.","family":"Des Jarlais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salaam","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugpo.2010.01.011","article-title":"Route transition interventions: potential public health gains from reducing or preventing injecting","volume":"21","author":"Bridge","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12026-009-8152-3","article-title":"Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence","volume":"47","author":"Burke","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000228928","article-title":"Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study","volume":"15","author":"Buster","year":"2009","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0020","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1360-0443.1997.tb02895.x","article-title":"The transition from injecting to smoking heroin in three Spanish cities","volume":"92","author":"de la Fuente","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2008.11.007","article-title":"Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City","volume":"101","author":"Des Jarlais","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City: a new stage in a very large HIV epidemic","volume":"21","author":"Des Jarlais","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1360-0443.2007.01764.x","article-title":"The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City","volume":"102","author":"Des Jarlais","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1360-0443.1992.tb01950.x","article-title":"AIDS and the transition to illicit drug injection: results of a randomized trial prevention program","volume":"87","author":"Des Jarlais","year":"1992","journal-title":"Br. J. Addict."},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2011.06.020_bib0045","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990\u20132001","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gcb.2010.09.004","article-title":"Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: no effect of current antiviral treatment coverage?","volume":"34","author":"Deuffic-Burban","year":"2010","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/09595230412331289437","article-title":"Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?","volume":"23","author":"Dolan","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0060","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/170.6.1410","article-title":"Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study","volume":"170","author":"Gerberding","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/1471-2458-10-721","article-title":"The provision of non-needle\/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review","volume":"10","author":"Gillies","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.addbeh.2004.03.012","article-title":"Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment","volume":"29","author":"Gossop","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2010.186","article-title":"Hepatitis C: enhancing treatment for hepatitis C among drug users","volume":"8","author":"Grebely","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2009.07.002","article-title":"HCV reinfection studies and the door to vaccine development","volume":"51","author":"Grebely","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugpo.2007.01.016","article-title":"HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection","volume":"18","author":"Hagan","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02350966","article-title":"Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs","volume":"77","author":"Hagan","year":"2000","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0095","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus (HCV) infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/649783","article-title":"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities","volume":"201","author":"Hagan","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0115","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1360-0443.2007.01998.x","article-title":"Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome","volume":"102","author":"Highfield","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09595239996310","article-title":"Preventing and curtailing injecting drug use: a review of opportunities for developing \u2018route transition interventions\u2019","volume":"18","author":"Hunt","year":"1999","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/09687639809006684","article-title":"Evaluation of a brief intervention to prevent initiation into injecting drugs","volume":"5","author":"Hunt","year":"1998","journal-title":"Educ. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/S095026880400247X","article-title":"Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France","volume":"132","author":"Lucidarme","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0135","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0140","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/09540120500100486","article-title":"Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents","volume":"17","author":"Mateu-Gelabert","year":"2005","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0740-5472(93)90092-G","article-title":"Decline in intravenous drug use among treatment-seeking opiate users","volume":"10","author":"Schottenfeld","year":"1993","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0150","series-title":"Right-Based Approaches to Public Health","article-title":"Human rights and HIV prevention among drug users","author":"Semaan","year":"2011"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0155","series-title":"Behavioral Interventions for Prevention and Control of Sexually Transmitted Diseases","first-page":"517","article-title":"The ethics of public health practice for the prevention and control of sexually transmitted diseases","author":"Semaan","year":"2007"},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.07.002","article-title":"The impact of injecting drug use status on hepatitis C-related referral and treatment","volume":"77","author":"Stoove","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0165","unstructured":"USAID, 2007. USAID Funded Drug Demand Reduction Program in Uzbekistan, Tajikistan and the Ferghana Valley of Kyrgyzstan. www.ddrprogram.org\/newsletter_eng.pdf (accessed 17.10.07)."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-006-9089-7","article-title":"Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users","volume":"22","author":"van den Berg","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2011.06.020_bib0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjmed.2006.02.030","article-title":"Frequent needle exchange use and HIV incidence in Vancouver, Canada","volume":"120","author":"Wood","year":"2007","journal-title":"Am. J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T04:26:51Z","timestamp":1543638411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611002985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0376871611002985"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.06.020","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}